| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/21/2004 | EP1439227A1 HPV-E6-specific siRNAs for the treatment of HPV-related tumors |
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439225A1 Dr5 gene promoter and siah-1 gene promoter |
| 07/21/2004 | EP1439223A1 Novel class ii cytokine receptor |
| 07/21/2004 | EP1439222A1 Method of detecting target nucleic acid and nucleic acid probe |
| 07/21/2004 | EP1439199A1 Medical polymers and use thereof |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439192A1 Neuropilin-1 inhibitors |
| 07/21/2004 | EP1439191A1 Process for the purification of bacterially expressed proteins |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1439189A2 86 Human Secreted Proteins |
| 07/21/2004 | EP1438584A1 Target assisted iterative screening (tais) : a novel screening format for large molecular repertoires |
| 07/21/2004 | EP1438438A2 Method for attaching nucleic acid molecules to electrically conductive surfaces |
| 07/21/2004 | EP1438437A2 Method for the detection of cytosine methylation in immobilised dna samples |
| 07/21/2004 | EP1438435A2 Methods for blocking nonspecific hybridizations of nucleic acid sequences |
| 07/21/2004 | EP1438434A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 07/21/2004 | EP1438431A2 Methods for diagnosing and treating heart disease |
| 07/21/2004 | EP1438430A2 Adaptive baseline algorithm for quantitative pcr |
| 07/21/2004 | EP1438426A1 Compositions and methods for using a solid support to purify rna |
| 07/21/2004 | EP1438425A2 69583 and 85924,novel human protein kinase family members and uses therefor |
| 07/21/2004 | EP1438419A2 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
| 07/21/2004 | EP1438418A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 07/21/2004 | EP1438413A2 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 07/21/2004 | EP1438412A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/21/2004 | EP1438411A2 Use of aminoglycoside resistance gene |
| 07/21/2004 | EP1438410A2 Promoters to control cell differentiation |
| 07/21/2004 | EP1438409A1 Use of a double strand ribonucleic acid for treating an infection with a positive-strand rna-virus |
| 07/21/2004 | EP1438408A2 Esr2 - a plant gene that can promote plant regeneration and transformation |
| 07/21/2004 | EP1438407A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 07/21/2004 | EP1438406A1 Drug for treating a carcinoma of the pancreas |
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |
| 07/21/2004 | EP1438404A2 Inhibition of specific histone deacetylase isoforms |
| 07/21/2004 | EP1438403A1 Nucleic acid isolation method and apparatus for performing same |
| 07/21/2004 | EP1438402A2 Modulators of bone homeostasis identified in a high-throughput screen |
| 07/21/2004 | EP1438401A2 Production of a transgenic avian by cytoplasmic injection |
| 07/21/2004 | EP1438400A1 Multi-chain eukaryotic display vectors and uses thereof |
| 07/21/2004 | EP1438399A2 Paramyxoviruses as gene transfer vectors to lung cells |
| 07/21/2004 | EP1438398A2 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
| 07/21/2004 | EP1438397A2 Plant reproduction polynucleotides and methods of use |
| 07/21/2004 | EP1438394A1 Pig mast cell cultures and uses thereof |
| 07/21/2004 | EP1438392A2 Cell populations which co-express cd49c and cd90 |
| 07/21/2004 | EP1438390A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 07/21/2004 | EP1438389A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 07/21/2004 | EP1438388A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 07/21/2004 | EP1438386A2 Transmembrane protein differentially expressed in cancer |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438340A2 Antibodies against kdr, their production and uses |
| 07/21/2004 | EP1438339A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 07/21/2004 | EP1438338A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 07/21/2004 | EP1438337A2 Crystals of cytochrome p450 2c9, structures thereof and their use |
| 07/21/2004 | EP1438334A2 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 07/21/2004 | EP1438331A1 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 07/21/2004 | EP1438325A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 07/21/2004 | EP1438075A2 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
| 07/21/2004 | EP1438074A2 Adjuvant compositions |
| 07/21/2004 | EP1438070A1 Treating vascular disease by inhibiting toll-like receptor-4 |
| 07/21/2004 | EP1438068A2 Antibody inhibitors of gdf-8 and uses thereof |
| 07/21/2004 | EP1438067A1 Autologous growth factor cocktail composition, method of production and use |
| 07/21/2004 | EP1438066A1 Incapacitated whole-cell immunogenic bacterial compositions |
| 07/21/2004 | EP1438062A2 Methods and compositions for treating dermal lesions |
| 07/21/2004 | EP1438056A1 Drug for treating a fibrotic disease through rna interfence |
| 07/21/2004 | EP1437936A2 Phytate polynucleotides and methods of use |
| 07/21/2004 | EP1437935A2 Manipulation of plant polysaccharide synthases |
| 07/21/2004 | EP1407011A4 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1 |
| 07/21/2004 | EP1348020A4 An optical method for testing sensitivity of cells |
| 07/21/2004 | EP1283668A4 Nucleic acids that control plant development |
| 07/21/2004 | EP1282715B1 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor |
| 07/21/2004 | EP1268833B1 Modified nodavirus rna for gene delivery |
| 07/21/2004 | EP1248854B1 rpoB GENE FRAGMENTS AND A METHOD FOR THE DIAGNOSIS AND IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS AND NON-TUBERCULOSIS MYCOBACTERIAL STRAINS |
| 07/21/2004 | EP1179057B1 pH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS |
| 07/21/2004 | EP1127146B1 Novel expression cassette for expressing genes in plant seed |
| 07/21/2004 | EP1068305B1 High throughput dna sequencing vector |
| 07/21/2004 | EP0977868B1 Yeast strains with interrupted atf2 gene and uses |
| 07/21/2004 | EP0974656B1 Dna gyrase inhibitor protein |
| 07/21/2004 | EP0970247B1 Detection of dna damaging agents |
| 07/21/2004 | EP0959904B1 Hybrid compositions for intracellular targeting |
| 07/21/2004 | EP0948604B1 Screening methods for compounds binding to the Pyk2 polypeptide |
| 07/21/2004 | EP0941329B1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 07/21/2004 | EP0866866B1 Mch3, an apoptotic protease, nucleic acids encoding and methods of use |
| 07/21/2004 | EP0815224B1 Receptor activation by gas6 |
| 07/21/2004 | EP0767176B1 Novel glyceroglycophospholipid, antibody there against, and method of detecting mycoplasma |
| 07/21/2004 | EP0635030B1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS |
| 07/21/2004 | CN1514880A Method and compositions for making emamectin |
| 07/21/2004 | CN1514879A Moraxella (branhamella) catarrhalis antigens |
| 07/21/2004 | CN1514878A Method for detecting calpain 3 activity in biological sample and peptides for implementsing said method |
| 07/21/2004 | CN1514876A Process for preparing transformed microorganism, D-aminoacylase |
| 07/21/2004 | CN1514844A Modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicity |
| 07/21/2004 | CN1514842A Processes of purifying oligonucleotides |
| 07/21/2004 | CN1514737A Method of treatment of vascular regeneration |
| 07/21/2004 | CN1514733A Modified erythropoietin (EPO) with reduced immunogenicity |
| 07/21/2004 | CN1514685A Tobacco biomass utilization |
| 07/21/2004 | CN1514005A Non-reductive saccharide formation enzyme, its preparation and application |
| 07/21/2004 | CN1514003A Construction method using detoxiase gene as stable expression system in silkworm |
| 07/21/2004 | CN1514002A Eucaryon expression system using jiadi flagllate virus as gene expression carrier |
| 07/21/2004 | CN1514001A High efficiency fast eucargon protein expression and production system |
| 07/21/2004 | CN1514000A Sodium alginate catenase gene algl and its preparation method and application |
| 07/21/2004 | CN1513999A New earthworm kinase gene mutant |
| 07/21/2004 | CN1513998A Sodium alginate lyase gene and its preparation method and application |
| 07/21/2004 | CN1513997A Method of detecting 5'-methioadenosine phosphorylase defect type mammarian cell |
| 07/21/2004 | CN1513996A Marek's disease virus vaccine CV1988 strain VP22 gene |